Q&A
-
Q&A
Abbott leader on the ‘hype’ and ‘reality’ of pulsed field ablation
Christopher Piorkowski, chief medical officer for the electrophysiology business, talks about the high expectations for the new atrial fibrillation treatment.
By Susan Kelly • March 1, 2024 -
Q&A
New GT Medical CEO Per Langoe on driving adoption of brain tumor therapy
Langoe, the former head of Palette Life Sciences, spoke about his plans to expand use of GT Medical’s cancer-fighting implant.
By Susan Kelly • Feb. 23, 2024 -
Q&A
Canary CEO Bill Hunter talks smart knee implant progress, new heart device
The company collaborated with Zimmer Biomet on its Persona IQ device, which is slated for a full market release this year. Canary is also working on an implantable monitor for heart failure patients.
By Elise Reuter • Feb. 15, 2024 -
Grail CEO predicts ‘transformative’ 2024 amid Illumina split
The liquid biopsy maker, which Illumina plans to divest, said it has made progress on a PMA application with the FDA for its Galleri multi-cancer early detection test.
By Susan Kelly • Dec. 19, 2023 -
Q&A
Moon Surgical CEO Anne Osdoit on readying a soft tissue robot for launch
With support from J&J’s venture capital arm and chip maker Nvidia, Moon is targeting a soft tissue surgery market dominated by Intuitive Surgical.
By Susan Kelly • Dec. 1, 2023 -
Q&A
Embecta CEO Dev Kurdikar talks about growth expectations, GLP-1s
The CEO said the company’s growth expectations have not changed in the near term, even with the rise of weight loss drugs.
By Elise Reuter • Nov. 21, 2023 -
Q&A
Stryker’s Lisa Kloes talks cementless implants, robotics as future of knee business
The manager of Stryker’s knee business also discussed the growing role of ambulatory surgery centers in orthopedics.
By Elise Reuter • Updated Nov. 8, 2023 -
Q&A
Baxter’s Heather Knight talks combating sepsis — and how AI can help
The company’s group president for medical products and therapies says the right fluid management practices can help save lives and lower hospital costs.
By Susan Kelly • Oct. 27, 2023 -
Q&A
GE HealthCare imaging CEO Jan Makela talks Mayo Clinic partnership
GE and Mayo Clinic plan to collaborate on imaging, artificial intelligence and cancer treatment.
By Elise Reuter • Oct. 6, 2023 -
Q&A
Bigfoot CEO talks Abbott acquisition, future of diabetes tech
Jeffrey Brewer hopes to see more integrated solutions for people with diabetes, starting with the company’s partnership with Abbott.
By Elise Reuter • Sept. 15, 2023 -
Q&A
Intuitive’s Tony Jarc on how AI is improving robotic surgery
The company aims to help surgeons achieve better results for patients and hospitals.
By Susan Kelly • Sept. 8, 2023 -
Q&A
ZimVie’s Rebecca Whitney sizes up the competition in cervical disc implants
The company is bringing new products to market as it faces more challengers in cervical disc replacement and tethering for scoliosis.
By Elise Reuter • Sept. 1, 2023 -
Q&A
Q&A: ‘Chaotic’ digital health market needs independent evaluation, new institute says
Independent evaluation could help the healthcare industry figure out which digital health products are backed by evidence, argues Caroline Pearson, executive director of the nonprofit Peterson Center on Healthcare.
By Emily Olsen • Aug. 11, 2023 -
Q&A: How Monogram’s CEO plans to disrupt robotic joint replacement surgery
The robot developer’s CEO, Benjamin Sexson, tells MedTech Dive why he believes the orthopedics market needs a fresh approach to joint reconstruction.
By Susan Kelly • Aug. 4, 2023 -
Q&A
Q&A: Penumbra CEO Adam Elsesser says new devices will drive changes in clot treatment
Penumbra has launched two devices that use computers to control suction of blood clots. That’s helped the company convert some surgeons from traditional methods of clot removal, like open surgery or drugs.
By Elise Reuter • July 7, 2023 -
Q&A
Q&A: Dexcom’s Lawver shares strategy behind CGM for non-insulin users
The continuous glucose monitor in development for people with Type 2 diabetes who don’t take insulin could expand the CGM market to 25 million more people in the U.S., the company’s new chief commercial officer said.
By Elise Reuter • June 30, 2023 -
Q&A
BD tech chief Beth McCombs talks about Parata acquisition, automation
As pharmacies and labs face cost pressures and staffing shortages, automation offers a way to save scarce healthcare dollars, McCombs says.
By Elise Reuter • June 16, 2023 -
Q&A
Friday Q&A: Biosense Webster’s Brooks and Hong talk about cardiac ablation
The leaders of Johnson & Johnson’s Biosense Webster unit see growth opportunities with new cardiac ablation technologies, despite a crowded field that includes Abbott, Boston Scientific and Medtronic.
By Elise Reuter • June 9, 2023 -
Q&A
How they built it: Florian Hillen wants to look at your teeth with his AI
Hillen is building a business on the premise that using artificial intelligence to examine dental X-rays can nearly double diagnostic accuracy, and help detect other diseases.
By Peter Green • June 7, 2023 -
Q&A
Friday Q&A: Stanford Biodesign’s Makower on expediting Medicare coverage for breakthrough devices
The director and co-founder of the Stanford Byers Center for Biodesign has been urging CMS to get patients access to breakthrough devices.
By Susan Kelly • Updated May 26, 2023 -
Q&A
Friday Q&A: Boston Scientific’s De Rosa on the rise of an AFib ‘game changer’
The Switzerland-based vice president of rhythm management for Europe, the Middle East and Africa expects a “massive shift” to pulsed field ablation from other atrial fibrillation treatments.
By Susan Kelly • May 5, 2023 -
Q&A
Friday Q&A: J&J’s Shan Jegatheeswaran talks about the ‘behind the scenes’ work of AI in medtech
The global head of digital solutions for J&J’s medtech unit says the intersection between software and how it’s used is an important, and often overlooked, aspect of AI.
By Elise Reuter • April 28, 2023 -
Q&A
Friday Q&A: Abbott’s Vish Charan on muscling into the leadless pacemaker market
Abbott is taking on Medtronic in the market for wireless devices to treat abnormally slow heart rhythms.
By Susan Kelly • April 21, 2023 -
Q&A
Friday Q&A: Medtronic’s Ajizian talks connected care ahead of unit spinoff
From supporting AI-driven medical interventions to freeing up providers from administrative tasks, remote patient monitoring is raising the bar for care, says Medtronic’s CMO for patient monitoring.
By Susan Kelly • April 15, 2023 -
Q&A
Friday Q&A: Movano takes on the women’s wearables market with a smart ring
Movano Health aims to stand out from the wearables crowd with a women’s health focus and strategy that is centered on obtaining FDA clearances.
By Susan Kelly • March 24, 2023